SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001178913-17-000577
Filing Date
2017-02-21
Accepted
2017-02-21 07:30:38
Documents
16
Period of Report
2016-12-31

Document Format Files

Seq Description Document Type Size
1 20-F zk1719594.htm 20-F 2585694
2 EXHIBIT 4.15 exhibit_4-15.htm EX-4.15 79064
3 EXHIBIT 4.16 exhibit_4-16.htm EX-4.16 151609
4 EXHIBIT 12.1 exhibit_12-1.htm EX-12.1 11539
5 EXHIBIT 12.2 exhibit_12-2.htm EX-12.2 11598
6 EXHIBIT 13.1 exhibit_13-1.htm EX-13.1 4370
7 EXHIBIT 13.2 exhibit_13-2.htm EX-13.2 4481
8 EXHIBIT 15.1 exhibit_15-1.htm EX-15.1 4173
9 image0.jpg GRAPHIC 237185
10 image00001.jpg GRAPHIC 67201
11 image1.jpg GRAPHIC 133846
12 image2.jpg GRAPHIC 91081
13 image3.jpg GRAPHIC 90404
14 image5.jpg GRAPHIC 24943
15 img101.jpg GRAPHIC 3295
16 img102.jpg GRAPHIC 3320
  Complete submission text file 0001178913-17-000577.txt   3750586
Mailing Address 42 HAYARKON STREET YAVNE L3 8122745
Business Address 42 HAYARKON STREET YAVNE L3 8122745 97289324010
MediWound Ltd. (Filer) CIK: 0001593984 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36349 | Film No.: 17623472
SIC: 2833 Medicinal Chemicals & Botanical Products